New supplementary therapies for the treatment of cancer-related diseases
GalChimia, Oncostellae and AMSLab take part in the research project Oncogalfarma, aiming at developing new supplementary therapies for the treatment of cancer-related diseases. Research is focused on the field of inhibitors of the protein-protein interaction (PPI) and nuclear receptors.
This project is funded by the Regional Government Xunta de Galicia and the ERDF in the framework of the Operational Programme ERDF Galicia 2007-2013 through the sub-programme CONECTA PEME.
Amount of the aid granted: EUR 114,745.76